Irreversible sinus node dysfunction induced by resumption of lithium therapy

Acta Psychiatrica Scandinavica

Volumn 93, Issue 5, 1996, Pages 407-408

  Terao, T ^a   Abe, H ^a   Abe, K ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

cardiac dysfunction; lithium

Indexed keywords

FLUNITRAZEPAM; HALOPERIDOL; LEVOMEPROMAZINE; LITHIUM; VALPROIC ACID;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HOLTER MONITORING; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SINUS NODE DYSFUNCTION;

EID: 0029980041     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb10668.x     Document Type: Article

References (6)

1. JOSEPH M, VIEWEG V. Electrocardiographic changes of sinus bradycardia and sinus node dysfunction among patients with therapeutic levels of lithium. Depression 1994/1995: 2: 226-231.
2. FONG R, HODDING GC, SIDALL D. Lithium carbonate causing reversible sinus node abnormalities? Drug Intell Clin Pharm 1978: 12: 671-672.
3. RODNEY WM, CHOPIVSKY P, HARA JH. Lithium-induced dysrhythmias as a marker for sick sinus syndrome. J Fam Pract 1983: 16: 797-799.
4. HAGMAN A, ARNMAN K, RYDEN L. Syncope caused by lithium treatment. Report on two cases and a prospective investigation of the prevalence of lithium-induced sinus node dysfunction. Acta Med Scand 1979: 205: 467-471.
5. PALILEO EV, COELHO A, WESTVEER D et al. Persistent sinus node dysfunction secondary to lithium therapy. Am Heart J 1983: 106: 1443-1444.
6. WEI JY. Age and the cardiovascular system. N Engl J Med 1992: 327: 1735-1739.